Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance
- PMID: 16368522
- DOI: 10.2741/1889
Dendritic cells and (CD4+)CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance
Abstract
Dendritic cells (DCs) are professional antigen presenting cells (APCs). (CD4+)CD25+ T regulatory cells (T regs) are recognized as professional regulatory cells. DCs not only initiate T cell immunity by uptake, processing and presentation of specific antigens, but also induce immune tolerance by deletion of T cells and/or induction of regulatory T cells. (CD4+)CD25+ T regs maintain immune tolerance by suppressing the function of CD4+ and CD8+ T cells, B cells, macrophages, DCs and NK cells. It would be inconceivable that the delicate balance between immunity and tolerance could be kept impeccable without the crosstalk between DCs and (CD4+)CD25+ T regs. This review focuses on the recent development in our understanding of DCs and (CD4+)CD25+ T regs in immune tolerance, with transforming growth factor-beta (TGF-beta) serving as a potential link between these two professionals.
Similar articles
-
Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.J Immunol. 2002 May 15;168(10):5058-69. doi: 10.4049/jimmunol.168.10.5058. J Immunol. 2002. PMID: 11994458
-
Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.J Immunol. 2007 Oct 15;179(8):5191-203. doi: 10.4049/jimmunol.179.8.5191. J Immunol. 2007. PMID: 17911604
-
IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.Immunobiology. 2014 Jan;219(1):17-24. doi: 10.1016/j.imbio.2013.06.008. Epub 2013 Jun 25. Immunobiology. 2014. PMID: 23891282
-
The characterization and role of regulatory T cells in immune reactions.Front Biosci. 2008 Jan 1;13:2266-74. doi: 10.2741/2840. Front Biosci. 2008. PMID: 17981708 Review.
-
Naturally occurring regulatory T cells: markers, mechanisms, and manipulation.FASEB J. 2012 Jun;26(6):2253-76. doi: 10.1096/fj.11-193672. Epub 2012 Feb 23. FASEB J. 2012. PMID: 22362896 Review.
Cited by
-
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.Breast Cancer Res. 2007;9(4):212. doi: 10.1186/bcr1746. Breast Cancer Res. 2007. PMID: 17705880 Free PMC article. Review.
-
Effective modulation of CD4(+)CD25 (+high) regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2.Cancer Immunol Immunother. 2012 Dec;61(12):2357-66. doi: 10.1007/s00262-012-1297-2. Epub 2012 Jun 22. Cancer Immunol Immunother. 2012. PMID: 22722448 Free PMC article.
-
Current state of type 1 diabetes immunotherapy: incremental advances, huge leaps, or more of the same?Clin Dev Immunol. 2011;2011:432016. doi: 10.1155/2011/432016. Epub 2011 Jul 18. Clin Dev Immunol. 2011. PMID: 21785616 Free PMC article. Review.
-
Immunotherapy for malignant glioma.Surg Neurol Int. 2015 Feb 13;6(Suppl 1):S68-77. doi: 10.4103/2152-7806.151341. eCollection 2015. Surg Neurol Int. 2015. PMID: 25722935 Free PMC article.
-
Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.Immunol Res. 2011 Aug;50(2-3):130-52. doi: 10.1007/s12026-011-8206-1. Immunol Res. 2011. PMID: 21476100
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous